EUVIMEDEUVIMED entdecken
Scoping Review

Biomarkers for the diagnosis and prognosis of sepsis according to its infectious source: a scoping review

Ronald Steven Arbeláez-Rodríguez, Valentina Lopez-Marroquin, Luz Elena Triana- Vidal

Infectio · 15.06.2026 · 167-176

DOI: 10.22354/24223794.1291 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Infectio, online erschienen am 15.06.2026. Verfasst von Ronald Steven Arbeláez-Rodríguez und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. This study aimed to map and classify the biomarkers reported in the literatura for the diagnosis and prognosis of sepsis, organizing them according to their frequency of occurrence in infections of the pulmonary, urinary, intra-abdominal, and skin and soft tissue origins. Materials and methods: A scoping review was conducted following the PRISMA-ScR guidelines using the Population–Concept–Context (PCC) framework. Studies with systematic review designs, meta-analyses, and cohort studies published between January 2019 and June 2025 in English or Spanish were included. The search strategy was applied to PubMed, ScienceDirect, SciELO, and Google Scholar, using MeSH terms and keywords combined with Boolean operators (AND, OR).

Results

The most consistent biomarkers for pulmonary sepsis, including presepsin and sFLT-1, were used for diagnosis and endotelial dysfunction, whereas plasma gelsolin and transcriptomic profiles (OTOF, SIGLEC1, MS4A4A) provided prognostic value. For urinary sepsis, NLR, PLR, NGAL, and KIM-1 stand out for the detection of complications, such as AKI, while presepsin and lactate were confirmed as robust prognostic markers. In abdominal sepsis, IL-18 and PSP emerge as complementary markers for differentiating foci and predicting complications, and CRP and PCT are useful in combination. For skin and soft tissue infections, YKL-40 and the lactate/albumin ratio show potential, although validation is lacking.

Discussion

The transition from classical biomarkers to emerging tolos with potential in precisión medicine has been confirmed, such as transcriptomic profiles and molecular technologies, which are particularly useful in the pulmonary and abdominal settings.

Zitieren

APA

Arbeláez-Rodríguez, R. S., Lopez-Marroquin, V., & Vidal, L. E. T. (2026). Biomarkers for the diagnosis and prognosis of sepsis according to its infectious source: a scoping review. Infectio, 167-176. https://doi.org/10.22354/24223794.1291

Vancouver

Arbeláez-Rodríguez RS, Lopez-Marroquin V, Vidal LET. Biomarkers for the diagnosis and prognosis of sepsis according to its infectious source: a scoping review. Infectio. 2026:167-176. doi:10.22354/24223794.1291

BibTeX
@article{ArbelezRodrguez2026,
  author = {Arbeláez-Rodríguez, Ronald Steven and Lopez-Marroquin, Valentina and Vidal, Luz Elena Triana-},
  title = {Biomarkers for the diagnosis and prognosis of sepsis according to its infectious source: a scoping review},
  journal = {Infectio},
  year = {2026},
  pages = {167--176},
  doi = {10.22354/24223794.1291}
}
Kostenlos starten →